Report on Health Care 2021
Canada is at the cusp of a multibillion-dollar industry in regenerative medicine that will disrupt health care and medicine, says the head of the Stem Cell Network.
Turn on the TV or flip through the latest bestseller list and it’s clear there’s a renewed interest in the potential of psychedelic drugs to provide emotional healing.
Rapid COVID-19 tests are widely viewed as a key tool for managing outbreaks, particularly among children as winter approaches and the highly infectious Delta variant remains the dominant strain in Canada.
More than half a million Canadians are living with dementia and that number is expected to nearly double by the end of the decade, according to The Alzheimer Society of Canada, driven by aging demographics and longer lifespans.
Picture an operating room where an artificial intelligence powered machine monitors a patient for imperceptible signs of trouble, warning doctors and nurses about adverse effects of a surgery before they become critical.
A scientific advancement that could change patients’ lives
After finding out her private health insurer would no longer pay for a drug helping with her cystic fibrosis, Lilia Zaharieva decided to sell everything she owned to stay on the medication.
Canada’s response to the COVID-19 pandemic has been choppy: A federal framework, combined with a patchwork of provincial and territorial strategies, created many of the same challenges the country’s health care system has been through in years past.
Canada is the only developed country in the world with a universal health care system that doesn’t include universal coverage of prescription drugs.
Talking Drugs: The road to commercialization